15-72349147-TAAG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_000520.6(HEXA):βc.915_917delβ(p.Phe305del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.000053 ( 0 hom., cov: 32)
Exomes π: 0.000068 ( 0 hom. )
Consequence
HEXA
NM_000520.6 inframe_deletion
NM_000520.6 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.51
Genes affected
HEXA (HGNC:4878): (hexosaminidase subunit alpha) This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_000520.6. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 15-72349147-TAAG-T is Pathogenic according to our data. Variant chr15-72349147-TAAG-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 188812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-72349147-TAAG-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEXA | NM_000520.6 | c.915_917del | p.Phe305del | inframe_deletion | 8/14 | ENST00000268097.10 | NP_000511.2 | |
HEXA | NM_001318825.2 | c.948_950del | p.Phe316del | inframe_deletion | 8/14 | NP_001305754.1 | ||
HEXA | NR_134869.3 | n.957_959del | non_coding_transcript_exon_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEXA | ENST00000268097.10 | c.915_917del | p.Phe305del | inframe_deletion | 8/14 | 1 | NM_000520.6 | ENSP00000268097 | P1 | |
ENST00000570175.1 | n.1578-1071_1578-1069del | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152168Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
8
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251444Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135894
GnomAD3 exomes
AF:
AC:
17
AN:
251444
Hom.:
AF XY:
AC XY:
8
AN XY:
135894
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461728Hom.: 0 AF XY: 0.0000701 AC XY: 51AN XY: 727198
GnomAD4 exome
AF:
AC:
99
AN:
1461728
Hom.:
AF XY:
AC XY:
51
AN XY:
727198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74462
GnomAD4 genome
AF:
AC:
8
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Tay-Sachs disease Pathogenic:4Other:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 17, 2017 | - - |
Affects, no assertion criteria provided | literature only | OMIM | Aug 01, 1992 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This variant, c.915_917del, results in the deletion of 1 amino acid(s) of the HEXA protein (p.Phe305del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs778155650, gnomAD 0.03%). This variant has been observed in individual(s) with Tay-Sachs disease (PMID: 1322637, 1825014, 1837283, 16088929). It is commonly reported in individuals of Moroccan ancestry (PMID: 1322637, 1825014). This variant is also known as p.F304del. ClinVar contains an entry for this variant (Variation ID: 188812). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects HEXA function (PMID: 1825014). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 16, 2021 | Variant summary: HEXA c.915_917delCTT (p.Phe305del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant allele was found at a frequency of 6.8e-05 in 251444 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in HEXA causing Tay-Sachs Disease (6.8e-05 vs 0.0014), allowing no conclusion about variant significance. c.915_917delCTT has been reported in the literature in multiple individuals affected with Tay-Sachs Disease, and has been reported as a common mutation in the Moroccan population (Navon_1991, Akli_1991, Montalvo_2005). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The variant was reported to render the alpha-subunit enzymatically inactive (Montalvo_2005). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Jun 05, 2014 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2024 | Transfection in COS-1 cells of the mutant protein demonstrated an impairment in the alpha subunit of beta-hexosaminidase A, resulting in an absence of enzyme activity (PMID: 1825014); In-frame deletion of 1 amino acid in a non-repeat region predicted to critically alter the protein; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 1322637, 16088929, 22789865, 1837283, 1825014) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at